STOCKWATCH
·
Pharmaceuticals
Dividend13 May 2025, 09:03 am

Morepen Board Proposes Dividend After 23 Years, Scores Highest PAT of Rs. 118 in FY25

AI Summary

Morepen Laboratories Ltd. board has proposed to declare a dividend (Rs.0.20 per share) after a gap of 23 years, marking a significant moment in the company's four-decade legacy. The proposal comes on the back of excellent financial results for FY25, with gross revenue rising to ~1,830 crore, a 7.4% year-on-year increase. EBITDA surged 21.6% to ¥118 crore, and Profit After Tax jumped to ~118 crore, while Earnings Per Share (EPS) climbed to ¥2.20, up 17% from the previous year.

Key Highlights

  • Morepen board proposes dividend after 23 years
  • Gross revenue for FY25 increased by 7.4% to ~1,830 crore
  • EBITDA surged by 21.6% to ¥118 crore
  • Profit After Tax jumped to ~118 crore
  • Earnings Per Share (EPS) climbed to ¥2.20, up 17% from the previous year
MOREPENLAB
Pharmaceuticals
MOREPEN LABORATORIES LTD.

Price Impact